Transcranial Magnetic Stimulation for Major Depressive Disorder
(rmPFC-Savoring Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a non-invasive brain stimulation and neuroimaging study that will examine how activity in the medial prefrontal cortex influences reward processing, particularly positive savoring, in individuals with depression. The central question is whether modulating medial prefrontal brain regions using transcranial magnetic stimulation (TMS) alters neural and behavioral responses to rewards. Brain activity will be recorded using both electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) while participants perform reward tasks. The primary objectives are to (1) identify patterns of brain activity linked to impaired reward processing in depression using EEG and fMRI, and (2) determine the causal role of specific prefrontal areas in these processes through targeted TMS. The methods include four sessions over four weeks: a clinical assessment, EEG recording during reward tasks after participants learn/practice positive savoring, an fMRI session, and a TMS session combined with EEG while participants practice positive savoring and perform reward tasks during EEG.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Clinical Assessment
Participants undergo a clinical assessment to establish baseline measures
EEG Recording
EEG recording during reward tasks after participants learn/practice positive savoring
fMRI Session
Participants undergo an fMRI session to record brain activity
TMS Session
TMS session combined with EEG while participants practice positive savoring and perform reward tasks
Follow-up
Participants are monitored for changes in neural and behavioral responses to rewards
What Are the Treatments Tested in This Trial?
Interventions
- Accelerated Intermittent Theta Burst Transcranial Magnetic Stimulation
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
Placebo Group
Accelerated intermittent theta burst will be delivered to left rostromedial prefrontal cortex, which has been previously shown to manipulate reward sensitivity. We are testing if this also impacts positive savoring as measured by the late positive potential during EEG and positive affect. This is an experimental condition that will be compared to an active comparator and a sham comparator.
Accelerated intermittent theta burst will be delivered to left dorsolateral prefrontal cortex, which is considered "treatment as usual" for depression.
Accelerated intermittent theta burst will be delivered to left primary somatosensory cortex, which is a placebo intervention condition.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Florida State University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.